Drugs / β-tricalcium phosphate Injectable Bone Graft
β-tricalcium phosphate Injectable Bone Graft
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07368114 Comparator | Dec 2023 → May 2025 | — | Suez Canal University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | β-tricalcium phosphate Injectable Bone Graft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07368114 ↗ |
| Modality | Other / unclassified | “grafting of injectable β-tricalcium phosphate (β-TCP) bone graft around the implant.” NCT07368114 ↗ |